Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (17)

2002

  1. Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine1a receptor ligands to explore the three-dimensional structure of the receptor

    Molecular Pharmacology, Vol. 62, Núm. 1, pp. 15-21

2001

  1. Transmembrane signaling through phospholipase C in cortical and hippocampal membranes of psychogenetically selected rat lines

    Psychopharmacology, Vol. 154, Núm. 2, pp. 115-125

1996

  1. Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional α2-adrenoceptors

    British Journal of Pharmacology, Vol. 117, Núm. 6, pp. 1286-1292

  2. Sustained increase in rat myocardial α1A-adrenoceptors induced by 6-hydroxydopamine treatment involves a decelerated receptor turnover

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 353, Núm. 4, pp. 408-416

1995

  1. Action on noradrenergic transmission of an anticholinesterase: 9-amino-1,2,3,4-tetrahydroacridine

    Neuropharmacology, Vol. 34, Núm. 4, pp. 367-375

1994

  1. Analysis of agonism at functional prejunctional α2-adrenoceptors of rat vas deferens using operational and null approaches

    European Journal of Pharmacology, Vol. 258, Núm. 3, pp. 229-238

  2. In vivo recovery of α1-adrenoceptors in rat myocardial tissue after alkylation with phenoxybenzamine

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 266, Núm. 1, pp. 35-42

  3. Selective enrichment with α1A- and α1B-adrenoceptor subtypes in rat brain cortical membranes

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 266, Núm. 3, pp. 301-308

1993

  1. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 264, Núm. 2, pp. 521-529

  2. Modulation of α1‐adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake

    British Journal of Pharmacology, Vol. 108, Núm. 3, pp. 678-683

1991

  1. Mechanisms underlying the differential sensitivity to α1-adrenoceptor activation in the bisected rat vas deferens

    British Journal of Pharmacology, Vol. 102, Núm. 2, pp. 439-445

1990

  1. Adaptational changes of α1-adrenoceptors in the bisected rat vas deferens after chronic inhibition of neuronal noradrenaline uptake

    European Journal of Pharmacology

  2. Effects of chronic antidepressant treatment on α1- and α2-adrenoceptors in the rat anococcygeus muscle

    Journal of Neural Transmission, Vol. 82, Núm. 3, pp. 205-212

  3. Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes

    European Journal of Pharmacology, Vol. 179, Núm. 3, pp. 295-299

1989

  1. BHT-920 and LY-171555 (quinpirole) have similar affinities for striatal D-2 dopamine receptors, and similar affinities for striatal D-1 dopamine receptors

    European Journal of Pharmacology, Vol. 166, Núm. 2, pp. 303-305

  2. Differential effects of chronic treatment with mianserin and protryptiline on rat brain cortical α1-adrenoceptors

    Brain Research, Vol. 498, Núm. 2, pp. 366-370

  3. Effects of St−587 on the α‐adrenoceptors in the Bisected Rat Vas Deferens

    Journal of Pharmacy and Pharmacology, Vol. 41, Núm. 9, pp. 612-616